AUP-60

N/A

Report date: 2025/01/22 12:03:45

Base Information

Drug NameAUP-60
Drug Alias NameAUP-60
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAurealis Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesAurealis Therapeutics AG
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A